On Holding Shares Rise After Raising Outlook Following Sales Surge
The Swiss athletic shoemaker now expects sales to increase at least 31% on a constant-currency basis year-over-year, while gross profit margin is forecast to be in the range of 60.5% to 61% in 2025. It previously guided for sales to increase 28% year-over-year and gross profit margin to be between 60% and 60.5%.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
16 minutes ago
- Yahoo
āshibio licences vantictumab for rare bone disorder
Biotechnology company āshibio has entered an exclusive licencing agreement with Mereo BioPharma for the monoclonal antibody, vantictumab, to treat a rare bone disorder. The agreement aims to facilitate antibody development for the autosomal dominant osteopetrosis type 2 (ADO2) bone condition that currently lacks approved therapies. āshibio will oversee clinical development of vantictumab globally for both adult and paediatric patients. Mereo has granted exclusive rights to āshibio for the development and commercialisation in the US and other regions outside of Europe, where Mereo retains commercial rights. ADO2, also referred to as Albers-Schönberg disease, is a genetic disorder characterised by reduced osteoclast function, leading to dense and brittle bones. It is linked to mutations in the chloride channel 7 (CLCN7) gene, with an incidence rate of one in 20,000 births. Āshibio CEO Pankaj Bhargava stated: 'People living with autosomal dominant osteopetrosis type 2 face a lifetime of bone-related complications resulting in significant morbidity, multiple surgical procedures, chronic pain and impaired quality of life – yet patients have no approved therapy to address the disease. 'Bringing vantictumab into our pipeline reflects our commitment to advancing therapies for rare skeletal conditions and improving the lives of those affected by serious bone disorders.' Vantictumab functions by selectively binding to specific frizzled (Fzd) receptors and inhibiting Wnt (wingless-related integration) signalling pathways. Initially developed for cancer treatment, it has undergone clinical trials in oncology showing a favourable safety and pharmacokinetic profile. Previous studies have generated biomarker data that support the efficacy of vantictumab on osteoclast function, which aids in reducing risks associated with the clinical programme and allows āshibio to expedite the advancement of vantictumab into clinical trials for ADO2. "āshibio licences vantictumab for rare bone disorder" was originally created and published by Pharmaceutical Technology, a GlobalData owned brand. The information on this site has been included in good faith for general informational purposes only. It is not intended to amount to advice on which you should rely, and we give no representation, warranty or guarantee, whether express or implied as to its accuracy or completeness. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site.
Yahoo
16 minutes ago
- Yahoo
Rising food bills put takeaways on hold
UK consumers are showing clear signs of restraint in their spending habits, with the latest Barclays Consumer Spending Report for July 2025 pointing to a slowdown in fast food and takeaway purchases. Overall spending in the eating and drinking category increased by just 0.8%, while bars, pubs, and clubs saw a 0.4% decline. Takeaway and fast food spending was virtually flat, inching up by only 0.1%, as households prioritise essentials over discretionary treats. Consumers cutting back as budgets tighten The findings underline how deeply the ongoing cost of living crisis continues to shape behaviour. More than half of consumers (51%) told Barclays they intend to cut discretionary spending, with 53% saying they will reduce fast food and takeaway purchases. Dining out is also under pressure, with 54% of people planning to eat at restaurants less often, while 42% are limiting what they spend on drinks at pubs and clubs. For many households, these decisions are not about choice but necessity. Rising rents, higher energy bills, and food price inflation have left little room for non-essential spending. Ordering a pizza or grabbing a quick meal from a fast food outlet is increasingly seen as a luxury rather than a cheap convenience. Grocery prices drive behaviour shifts Grocery inflation has eased slightly in recent months but remains high enough to pressure household budgets. Even small increases in weekly shopping bills force consumers to reconsider their priorities. Shoppers are focusing more on stretching their grocery spend, often opting for supermarket own-label products, discount retailers, and meal planning at home rather than spending on takeaways. This shift highlights how rising grocery costs have a double impact on consumer behaviour. On one hand, families are tightening control over food budgets at supermarkets; on the other, they are cutting back on fast food and dining out to make room for unavoidable grocery expenses. In effect, higher supermarket prices are squeezing discretionary food spend across the board. What retailers can learn from selective spending For retailers, the message is clear: shoppers want value, and they are willing to switch habits to find it. Discount grocers and supermarkets with strong own-label ranges are well placed to capture demand from budget-conscious households. Promotions that focus on meal solutions—such as affordable recipe bundles, family packs, or price-locked staples—can help retailers position themselves as allies in the battle against rising costs. Foodservice operators face a tougher landscape, but opportunities remain for those who can highlight value, convenience, or healthier alternatives. Loyalty schemes, bundled offers, and affordable menu options are likely to resonate most strongly with a cautious consumer base. Looking ahead The Barclays report confirms that fast food spending has stalled as households navigate the ongoing cost of living crisis. High grocery prices are forcing shoppers to think carefully about every pound, reshaping the way they spend on both everyday essentials and occasional treats. For retailers and food operators alike, the challenge is to adapt strategies that balance affordability with quality, helping consumers feel that their money goes further. Those who succeed will be best positioned to weather the selective spending environment and maintain relevance in a cautious market. "Rising food bills put takeaways on hold" was originally created and published by Retail Insight Network, a GlobalData owned brand. The information on this site has been included in good faith for general informational purposes only. It is not intended to amount to advice on which you should rely, and we give no representation, warranty or guarantee, whether express or implied as to its accuracy or completeness. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site. Sign in to access your portfolio
Yahoo
16 minutes ago
- Yahoo
Sales of foreign-branded phones in China down 31.3% in June, data shows
BEIJING (Reuters) -Sales of foreign-branded phones, including Apple Inc's (AAPL) iPhone, declined 31.3% year-on-year in China in June, according to Reuters' calculations based on data released on Wednesday by a government-affiliated research firm. The shipments of foreign-branded phones had slid to 1.971 million units in June, from 2.869 million handsets the same month a year earlier, calculations based on the data from the China Academy of Information and Communications Technology (CAICT) showed. Overall phone sales in China fell 9.3% to 22.598 million units in June, according to the data. Sign up for the Yahoo Finance Morning Brief By subscribing, you are agreeing to Yahoo's Terms and Privacy Policy Error while retrieving data Sign in to access your portfolio Error while retrieving data Error while retrieving data Error while retrieving data Error while retrieving data
